Decline in NRF2-regulated Antioxidants in Chronic Obstructive Pulmonary Disease Lungs Due to Loss of Its Positive Regulator, DJ-1
Deepti Malhotra(Bloomberg (United States)), Shyam Biswal(Sidney Kimmel Comprehensive Cancer Center), Xiaoxi Zhuang(University of Chicago), Rubin M. Tuder(University of Colorado Denver), Ana Navas‐Acién(University of Southern California), Linan Chen(University of Chicago), James C. Hogg(University of British Columbia), Mark Elliott(University of British Columbia), Anju Singh(Johns Hopkins University), Rajesh K. Thimmulappa(Johns Hopkins University), Peter D. Paré(University of British Columbia), Andrew J. Sandford(University of British Columbia)
Cited by 354
Related Papers
Social Determinants of Health and Diabetes: A Scientific Review
|Diabetes Care|2020|1.6k
Lead Exposure and Cardiovascular Disease—A Systematic Review
|Environmental Health Perspectives|2006|1.1k
Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
|PLoS Medicine|2006|1k
Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis
|Journal of Clinical Investigation|2006|1k
Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke–induced emphysema in mice
|Journal of Clinical Investigation|2004|879